Artiva Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: Nov 12, 2024
Expanded Board of Directors with appointment of Dr. Alison Moore bringing cell therapy and manufacturing expertise to advance AlloNK® in autoimmune diseases
Read more at globenewswire.com
